BSE Live
Jan 14, 16:01Prev. Close
71.42
Open Price
71.42
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 14, 15:59Prev. Close
71.47
Open Price
71.21
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
69.23 (5)
| Key Financial Ratios of Brooks Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 5.85 | 4.47 | 4.41 | 6.55 | 6.97 | |
| Diluted EPS (Rs.) | 5.85 | 4.47 | 4.41 | 6.55 | 7.00 | |
| Cash EPS (Rs.) | 6.53 | 4.99 | 4.92 | 5.86 | 7.59 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 68.83 | 69.37 | 65.12 | 56.38 | 19.65 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 68.83 | 69.37 | 65.12 | 56.38 | 19.65 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 52.64 | 52.68 | 49.49 | 34.64 | 53.14 | |
| PBDIT/Share (Rs.) | 5.63 | 5.26 | 6.49 | 7.13 | 9.51 | |
| PBIT/Share (Rs.) | 4.95 | 4.75 | 5.99 | 6.73 | 8.89 | |
| PBT/Share (Rs.) | 6.39 | 4.68 | 5.92 | 5.67 | 7.38 | |
| Net Profit/Share (Rs.) | 5.85 | 4.47 | 4.41 | 5.46 | 6.97 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 10.69 | 9.99 | 13.12 | 20.59 | 17.89 | |
| PBIT Margin (%) | 9.39 | 9.01 | 12.10 | 19.41 | 16.73 | |
| PBT Margin (%) | 12.14 | 8.87 | 11.96 | 16.35 | 13.88 | |
| Net Profit Margin (%) | 11.11 | 8.49 | 8.91 | 15.75 | 13.11 | |
| Return on Networth / Equity (%) | 8.49 | 6.44 | 6.77 | 9.68 | 35.45 | |
| Return on Capital Employed (%) | 8.34 | 6.32 | 6.65 | 9.55 | 32.26 | |
| Return on Assets (%) | 7.00 | 5.15 | 5.42 | 8.35 | 16.85 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.01 | 0.00 | 0.45 | |
| Asset Turnover Ratio (%) | 63.05 | 60.71 | 60.84 | 53.00 | 128.57 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.52 | 2.69 | 2.71 | 3.05 | 0.87 | |
| Quick Ratio (X) | 2.17 | 2.45 | 2.51 | 2.66 | 0.58 | |
| Inventory Turnover Ratio (X) | 11.31 | 14.14 | 16.08 | 10.87 | 9.55 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 14.35 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 13.18 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 85.65 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 86.82 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 39.50 | -0.07 | 3.52 | 7.78 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.46 | 0.00 | 0.04 | 0.14 | 0.00 | |
| EV/EBITDA (X) | 4.33 | -0.01 | 0.33 | 0.67 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.73 | 0.35 | 0.33 | 0.47 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 85.64 | |
| Price/BV (X) | 0.56 | 0.27 | 0.25 | 0.29 | 0.00 | |
| Price/Net Operating Revenue | 0.73 | 0.35 | 0.33 | 0.47 | 0.00 | |
| Earnings Yield | 0.15 | 0.24 | 0.27 | 0.33 | 0.00 |
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y